Abingdon Health plc (ABDX) · 2026-09-29
UKAS ISO/IEC 17025 accreditation
Abingdon Analytical has received its first UKAS ISO/IEC 17025:2017 accreditation for its Doncaster performance-evaluation laboratory, providing customers with independently assessed confidence in studies performed within its accredited scope and strengthening Abingdon Health’s diagnostic-development and regulatory-support offering.
Abingdon Health plc (ABDX) · 2026-09-25
Official opening of manufacturing hub in the US
Abingdon Health has opened a manufacturing hub in Madison, Wisconsin, adding US infrastructure and capacity for its diagnostic-testing CDMO services. The company says the facility supports expansion in the US market, but disclosed no financial contribution or guidance.
Abingdon Health plc (ABDX) · 2026-07-29
Trading update
Abingdon Health expects FY26 revenue including grant-funded income to rise 31% to GBP11.3m from GBP8.6m, and said it reached adjusted EBITDA profitability in H2. The update remains subject to finalisation of FY26 results.
Abingdon Health plc (ABDX) · 2026-05-27
US tax credit agreement
Abingdon Health has been certified for up to $370,000 in performance-based Wisconsin tax credits over three years. The credits support job creation and capital investment at the Group's facility in Madison, Wisconsin.